Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074627 · ClinicalTrials.gov registry record · NA
Radicle Energy2: A Study of Health and Wellness Products on Fatigue and Other Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,189
- Enrollment target
NCT06074627: Completed NA study, sponsored by Radicle Science.
NCT06074627 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 1,189 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06074627, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,189 participants
- Enrollment target
Study Summary
A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on fatigue and other health outcomes
Primary Outcome
Mean difference in fatigue score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 8A (scale 8-40; where higher scores correspond to more severe fatigue)
Interventions
- DIETARY_SUPPLEMENT Energy Placebo Control Form 1
- DIETARY_SUPPLEMENT Energy Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Energy Active Study Product 1.2 Usage
- DIETARY_SUPPLEMENT Energy Active Study Product 1.3 Usage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,189 participants |
| Start Date | 2023-09-26 |
| Est. Completion | 2024-05-03 |
| Phase | NA |
What the finished NCT06074627 record still lists
NCT06074627 is an interventional study that assigns participants to a tested intervention. Its 1,189 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 4 interventions - of which Energy Placebo Control Form 1 is the first listed.
NCT06074627 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06074627 about?
NCT06074627 is a clinical study titled "Radicle Energy2: A Study of Health and Wellness Products on Fatigue and Other Health Outcomes". A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on fatigue and other health outcomes
What is the current status of trial NCT06074627?
This trial is currently completed. It is a NA study. The enrollment target is 1,189 participants. The study started on 2023-09-26. Estimated completion is 2024-05-03.
What interventions are being tested in trial NCT06074627?
The interventions under investigation include: Energy Placebo Control Form 1 (DIETARY_SUPPLEMENT), Energy Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Energy Active Study Product 1.2 Usage (DIETARY_SUPPLEMENT), Energy Active Study Product 1.3 Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06074627?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06074627's enrollment target sits among peer trials
1,189 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT07177339 · 1,196 participants · Phase 3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI